![]() |
UMIN-CTR Clinical Trial |
|
![]() |
![]() |
![]() |
![]() |
Name: | UMIN ID: |
Recruitment status | Enrolling by invitation |
Unique ID issued by UMIN | UMIN000003787 |
Receipt No. | R000004581 |
Scientific Title | Chemically assisted ESD in the esophagus and the colon |
Date of disclosure of the study information | 2010/06/21 |
Last modified on | 2012/11/09 |
Basic information | ||
Public title | Chemically assisted ESD in the esophagus and the colon | |
Acronym | CA-ESD in the esophagus and the colon | |
Scientific Title | Chemically assisted ESD in the esophagus and the colon | |
Scientific Title:Acronym | CA-ESD in the esophagus and the colon | |
Region |
|
Condition | ||
Condition | Early stage esophageal cancer, esophageal dysplasia, early stage colonic cancer, and colonic adenoma with an indication of ESD | |
Classification by specialty |
|
|
Classification by malignancy | Malignancy | |
Genomic information | NO |
Objectives | |
Narrative objectives1 | ESD has enabled us to radically excise superficial gastrointestinal (GI) tumors at any level of the GI tract regardless of lesion size. However, ESD is technically challenging and may carries a higher risks of complications especially in the esophagus and the colon with thinner mural thickness. Preceding animal and pilot clinical studies demonstrated that the submucosal injection of one of mucolytic agents, so called mesna chemically soften the submucosal tissue plane and facilitate submucosal dissection process in ESD in the stomach. In this study, we will evaluate this chemical effect of mesna for ESD in the esophagus and the colon. |
Basic objectives2 | Safety,Efficacy |
Basic objectives -Others | |
Trial characteristics_1 | |
Trial characteristics_2 | |
Developmental phase |
Assessment | |
Primary outcomes | Procedural success rate |
Key secondary outcomes | En bloc resection rate
Complication and side effect rate The healing process of post-therapeutic ulcerations Histological analysis of sampled specimens |
Base | |
Study type | Interventional |
Study design | |
Basic design | Single arm |
Randomization | Non-randomized |
Randomization unit | |
Blinding | Open -no one is blinded |
Control | Uncontrolled |
Stratification | |
Dynamic allocation | |
Institution consideration | |
Blocking | |
Concealment |
Intervention | ||
No. of arms | 1 | |
Purpose of intervention | Treatment | |
Type of intervention |
|
|
Interventions/Control_1 | Using mesna as a submucosal injection solution. | |
Interventions/Control_2 | ||
Interventions/Control_3 | ||
Interventions/Control_4 | ||
Interventions/Control_5 | ||
Interventions/Control_6 | ||
Interventions/Control_7 | ||
Interventions/Control_8 | ||
Interventions/Control_9 | ||
Interventions/Control_10 |
Eligibility | ||||
Age-lower limit |
|
|||
Age-upper limit |
|
|||
Gender | Male and Female | |||
Key inclusion criteria | Superficial lesions in the esophagus and the colon with indication of ESD removal. | |||
Key exclusion criteria | History of hypersensitivity to mesna and women who were pregnant, lactating, or hoping to become pregnant during this study period | |||
Target sample size | 60 |
Research contact person | |||||||
Name of lead principal investigator |
|
||||||
Organization | The Jikei University School of Medicine | ||||||
Division name | Department of Endoscopy | ||||||
Zip code | |||||||
Address | 3-25-8 Nishi Shinbashi, Minato-ku, Tokyo 105-8461, Japan | ||||||
TEL | |||||||
Public contact | |||||||
Name of contact person |
|
||||||
Organization | The Jikei University School of Medicine | ||||||
Division name | Department of Endoscop | ||||||
Zip code | |||||||
Address | |||||||
TEL | |||||||
Homepage URL | |||||||
kaz_sum@jikei.ac.jp |
Sponsor | |
Institute | The Jikei University School of Medicine |
Institute | |
Department |
Funding Source | |
Organization | Research fund of The Jikei University School of Medicine, Department of Endoscopy. |
Organization | |
Division | |
Category of Funding Organization | Self funding |
Nationality of Funding Organization |
Other related organizations | |
Co-sponsor | |
Name of secondary funder(s) |
IRB Contact (For public release) | |
Organization | |
Address | |
Tel | |
Secondary IDs | |
Secondary IDs | NO |
Study ID_1 | |
Org. issuing International ID_1 | |
Study ID_2 | |
Org. issuing International ID_2 | |
IND to MHLW |
Institutions | |
Institutions |
Other administrative information | |||||||
Date of disclosure of the study information |
|
Related information | |
URL releasing protocol | |
Publication of results | Unpublished |
Result | |
URL related to results and publications | |
Number of participants that the trial has enrolled | |
Results | |
Results date posted | |
Results Delayed | |
Results Delay Reason | |
Date of the first journal publication of results | |
Baseline Characteristics | |
Participant flow | |
Adverse events | |
Outcome measures | |
Plan to share IPD | |
IPD sharing Plan description |
Progress | |||||||
Recruitment status | Enrolling by invitation | ||||||
Date of protocol fixation |
|
||||||
Date of IRB | |||||||
Anticipated trial start date |
|
||||||
Last follow-up date | |||||||
Date of closure to data entry | |||||||
Date trial data considered complete | |||||||
Date analysis concluded |
Other | |
Other related information |
Management information | |||||||
Registered date |
|
||||||
Last modified on |
|
Link to view the page | |
URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000004581 |
Research Plan | |
Registered date | File name |
Research case data specifications | |
Registered date | File name |
Research case data | |
Registered date | File name |